Dienogest in endometriosis treatment: A narrative literature review
Clinical and Experimental Reproductive Medicine · 01.12.2023 · 50 (4) · 223-229
DOI: 10.5653/cerm.2023.06128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Reproductive Medicine, erschienen am 01.12.2023. Verfasst von Joowon Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Endometriosis is characterized by the implantation of endometrial cells outside the uterus. This hormone-dependent disease is highly prevalent among women of reproductive age. Clinical symptoms of endometriosis include dysmenorrhea, pelvic pain, and infertility, which can negatively impact the overall quality of life of those affected. The medical treatment of endometriosis serves as an important therapeutic option, aimed at alleviating pain associated with the condition and suppressing the growth of endometriotic lesions. As such, it is employed as an adjuvant therapy following surgery or an empirical treatment after the clinical diagnosis of endometriosis. Dienogest, a fourth-generation progestin, has received approval for the treatment of endometriosis in many countries. A growing body of evidence has demonstrated its efficacy in managing endometriosis-associated pain, preventing symptoms, and reducing lesion recurrence. In this review, we examine the clinical efficacy, safety, and tolerability of dienogest in treating endometriosis. We also provide updated findings, drawing from clinical studies that focus on the long-term use of this medication in patients with endometriosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Lee, J., Park, H. J., & Yi, K. W. (2023). Dienogest in endometriosis treatment: A narrative literature review. Clinical and Experimental Reproductive Medicine, 50(4), 223-229. https://doi.org/10.5653/cerm.2023.06128
Vancouver
Lee J, Park HJ, Yi KW. Dienogest in endometriosis treatment: A narrative literature review. Clinical and Experimental Reproductive Medicine. 2023;50(4):223-229. doi:10.5653/cerm.2023.06128
BibTeX
@article{Lee2023,
author = {Lee, Joowon and Park, Hyeon Ji and Yi, Kyong Wook},
title = {Dienogest in endometriosis treatment: A narrative literature review},
journal = {Clinical and Experimental Reproductive Medicine},
year = {2023},
volume = {50},
number = {4},
pages = {223--229},
doi = {10.5653/cerm.2023.06128}
}
EUVIMED